NDT Advance Access originally published online on August 3, 2007
Nephrology Dialysis Transplantation 2007 22(12):3370-3377; doi:10.1093/ndt/gfm524
© The Author [2007]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Mannose-binding lectin and the kidney
Anja Roos1,2,
Mohamed R. Daha2,
Johannes van Pelt1 and
Stefan P. Berger2
1Department of Clinical Chemistry and 2Department of Nephrology, Leiden University Medical Center, Leiden, The Netherlands
Correspondence to: Anja Roos, PhD, Department of Clinical Chemistry, L2-27, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands. Email: A.Roos@LUMC.NL
Keywords: complement; diabetes; ficolin; IgA nephropathy; ischaemia/reperfusion injury; lectin pathway; mannose binding lectin; transplantation
| The first 150 words of the full text of this article appear below. |
 |
Introduction
|
|---|
The complement system is a key component of innate immunity
that plays a major role in host defense against invading pathogens.
This is effectuated by a direct attack of pathogens, by mediating
inflammation and opsonin-dependent phagocytosis, and by induction
and amplification of adaptive immunity. In recent years, it
has become increasingly clear that the complement system also
plays an important role in immune homeostasis in the healthy
situation. In this respect, genetic complement deficiencies
are not only associated with infectious diseases, but also with
auto-immune and inflammatory diseases. Among the complement
deficiencies described in humans, deficiency of the complement
factor mannose-binding lectin (MBL) has the highest frequency.
Due to its large genetic heterogeneity, MBL is a highly interesting
and attractive object of study, and many studies have now revealed
the association of a variety of human diseases with the MBL
status, being either MBL-deficient or MBL-sufficient. These
studies demonstrate that
. . . [Full Text of this Article]
 |
MBL and the lectin pathway of complement
|
|---|
 |
MBL and IgA nephropathy
|
|---|
 |
MBL and diabetic nephropathy
|
|---|
 |
MBL and I/R injury
|
|---|
 |
MBL and renal transplantation
|
|---|
 |
MBL and the kidney: conclusions
|
|---|

CiteULike
Connotea
Del.icio.us What's this?